2020 ASCO Virtual Direct™ Highlights
Breast
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on mTNBC: Does Atezolizumab + Chemo Combo Improve PFS?
FEATURING
Elyse Lower
- 217 views
- October 13, 2020
- 2
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on MBC: Is Olaparib Beneficial for Disease With sBRCA1/2 or gPALB2 Mutations?
FEATURING
Elyse Lower
- 221 views
- October 13, 2020
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on HR+ MBC: Is Fulvestrant + CDKi Associated With Improved PFS and OS?
FEATURING
Elyse Lower
- 359 views
- October 13, 2020
- 3
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on HR+ BC: Does Neoadjuvant Endocrine Combination Therapy Have a Greater Effect on ESDR vs. Monotherapy in Early Stage BC? Should We Consider MammaPrint a Guidance Tool for Precision Adjuvant Therapy?
FEATURING
Kevin Kalinsky
- 523 views
- August 6, 2020
- 4
2020 ASCO Virtual Direct™ Highlights
2020 ASCO Highlights on HER2+ MBC: Incorporating New HER2 Targeted Agents - Neratinib, Pertuzumab & T-DM-1
FEATURING
Kevin Kalinsky
- 220 views
- August 26, 2020
- 2